CTX131
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CTX131, covering 2025-11-26 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies [Phase 1, Phase 2]